{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:07:45Z","timestamp":1761764865270},"reference-count":23,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,7,20]],"date-time":"2006-07-20T00:00:00Z","timestamp":1153353600000},"content-version":"vor","delay-in-days":6409,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Prostate"],"published-print":{"date-parts":[[1989,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The contractile response of human prostate adenomas to KCI, phenylephrine (alpha<jats:sub>1<\/jats:sub> adrenergic agonist), UK 14304 (alpha<jats:sub>2<\/jats:sub> adrenergic agonist), and carbachol (muscarinic cholinergic agonist) was evaluated in tissue specimens obtained from men with symptomatic and asymptomatic BPH. Prostate specimens were obtained from 5 men with asymptomatic BPH undergoing cystoprostatectomy, 11 men with symptomatic BPH undergoing open prostatectomy, and 11 men with symptomatic BPH undergoing transurethral resection of the prostate (TURP). Quantitative symptom score analysis and urinary flow rate determination documented the absence of bladder outlet obstruction in men undergoing cystoprostatectomy and confirmed the presence of bladder outlet obstruction in men undergoing prostatectomy. The magnitude of the contractile response (E<jats:sub>max<\/jats:sub>) and the potency of phenylephrine\u2010induced contractions (EC<jats:sub>50<\/jats:sub>) in prostatic preparations obtained from men with symptomatic and asymptomatic BPH were similar. The IC<jats:sub>50<\/jats:sub> for the inhibition of phenylephrine\u2010induced contractions by prazosin was 3.2 nM, confirming that phenylephrineinduced contraction in the human prostate is mediated by the alpha<jats:sub>1<\/jats:sub> adrenoceptor. The contractile responses of prostate adenomas to muscarinic cholinergic and alpha<jats:sub>2<\/jats:sub> agonists were negligible. This study demonstrates that the development of bladder outlet obstruction in men with BPH is not related to alterations in the functional response of the smooth muscle component of the prostate adenoma.<\/jats:p>","DOI":"10.1002\/pros.2990150204","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T01:38:31Z","timestamp":1172021911000},"page":"105-114","source":"Crossref","is-referenced-by-count":64,"title":["Contractile properties of human prostate adenomas and the development of infravesical obstruction"],"prefix":"10.1002","volume":"15","author":[{"given":"Daniel I.","family":"Gup","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Lepor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,20]]},"reference":[{"doi-asserted-by":"publisher","key":"e_1_2_1_2_2","DOI":"10.1111\/j.1464-410X.1973.tb12237.x"},{"doi-asserted-by":"publisher","key":"e_1_2_1_3_2","DOI":"10.1111\/j.1464-410X.1975.tb03947.x"},{"doi-asserted-by":"publisher","key":"e_1_2_1_4_2","DOI":"10.1002\/bjs.1800641019"},{"doi-asserted-by":"publisher","key":"e_1_2_1_5_2","DOI":"10.1111\/j.1464-410X.1978.tb06210.x"},{"doi-asserted-by":"publisher","key":"e_1_2_1_6_2","DOI":"10.1111\/j.1464-410X.1982.tb13581.x"},{"key":"e_1_2_1_7_2","first-page":"29","article-title":"Phenoxybenzamine reduces bladder outlet obstruction in benign prostatic hyperplasia","volume":"18","author":"Gerstenberg T","year":"1980","journal-title":"Invest Urol"},{"doi-asserted-by":"publisher","key":"e_1_2_1_8_2","DOI":"10.1016\/S0022-5347(17)51106-4"},{"doi-asserted-by":"publisher","key":"e_1_2_1_9_2","DOI":"10.1016\/0090-4295(83)90044-4"},{"key":"e_1_2_1_10_2","first-page":"10","article-title":"The effects of prazosin in benign prostatic hypertrophy, a placebo controlled double\u2010blind study","volume":"12","author":"Martorana G","year":"1984","journal-title":"IRCS Med Sci"},{"doi-asserted-by":"publisher","key":"e_1_2_1_11_2","DOI":"10.1111\/j.1464-410X.1987.tb04950.x"},{"doi-asserted-by":"publisher","key":"e_1_2_1_12_2","DOI":"10.1016\/0090-4295(77)90215-1"},{"doi-asserted-by":"publisher","key":"e_1_2_1_13_2","DOI":"10.1016\/S0022-5347(17)53216-4"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0022-5347(17)50110-X","article-title":"Characterization of alpha1 adrenergic receptors in human benign prostatic hyperplasia","volume":"132","author":"Lepor H","year":"1984","journal-title":"J Urol"},{"doi-asserted-by":"publisher","key":"e_1_2_1_15_2","DOI":"10.1111\/j.1476-5381.1988.tb16557.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0022-5347(17)45971-4","article-title":"Alpha2 adrenergic receptors in hyperplastic human prostate: Identification and characterization using (3H)\u2010rauwolscine","volume":"135","author":"Shapiro E","year":"1986","journal-title":"J Urol"},{"key":"e_1_2_1_17_2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0022-5347(17)49636-4","article-title":"Characterization and localization of the muscarinic cholinergic receptor in human prostatic tissues","volume":"132","author":"Lepor H","journal-title":"J Urol"},{"key":"e_1_2_1_18_2","first-page":"2609","article-title":"Comparision of the alpha\u2010adrenoceptor characteristics in human and canine prostate","volume":"45","author":"Hieble JP","year":"1986","journal-title":"Fed Proc"},{"doi-asserted-by":"publisher","key":"e_1_2_1_19_2","DOI":"10.1016\/S0022-5347(17)47714-7"},{"key":"e_1_2_1_20_2","first-page":"288","article-title":"The male genitourinary sphincter mechanism in the dog","volume":"15","author":"Bruschini H","year":"1978","journal-title":"Invest Urol"},{"doi-asserted-by":"publisher","key":"e_1_2_1_21_2","DOI":"10.1016\/S0022-5347(17)44107-3"},{"key":"e_1_2_1_22_2","first-page":"29","article-title":"A new look at bladder neck obstruction by the Food and Drug Administration regulators: Guidelines for investigation of benign prostatic hypertrophy","volume":"68","author":"Boyarksy S","year":"1977","journal-title":"Trans Am Assoc Genitourin Surg"},{"doi-asserted-by":"publisher","key":"e_1_2_1_23_2","DOI":"10.1016\/S0022-5347(17)43034-5"},{"doi-asserted-by":"publisher","key":"e_1_2_1_24_2","DOI":"10.1016\/S0022-5347(17)49698-4"}],"container-title":["The Prostate"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.2990150204","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pros.2990150204","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T16:35:22Z","timestamp":1697992522000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pros.2990150204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,1]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1989,1]]}},"alternative-id":["10.1002\/pros.2990150204"],"URL":"https:\/\/doi.org\/10.1002\/pros.2990150204","archive":["Portico"],"relation":{},"ISSN":["0270-4137","1097-0045"],"issn-type":[{"type":"print","value":"0270-4137"},{"type":"electronic","value":"1097-0045"}],"subject":[],"published":{"date-parts":[[1989,1]]}}}